معرفی
Paul Renauer is a Researcher in the Department of Genetics at Yale School of Medicine, Yale University. He holds a PhD in Genetics from Yale University (2022) and a BSc in Biochemistry from the University of Michigan (2013). His research focuses on immunotherapy, CRISPR technology, cancer biology, and vaccine development, with a particular emphasis on CAR-T and CAR-NK cell therapies, genetic engineering of immune cells, and mRNA-based vaccine strategies. Renauer has contributed to groundbreaking work in identifying genetic checkpoints in immunotherapy, optimizing CAR-T cell metabolism, and developing polyvalent mRNA vaccines against viral pathogens like SARS-CoV-2 and monkeypox.
- Education:
- PhD in Genetics, Yale University (2022)
- BSc in Biochemistry, University of Michigan (2013)
- Research Interests:
- CRISPR-based genetic screens for immunotherapy targets
- Engineering T and NK cells for cancer treatment
- mRNA vaccine design and multiplexing
- Metabolic modulation of CAR-T cell function
- Scientific Awards:
- Lo Graduate Fellowship for Excellence in Stem Cell Research (2020)
- Outstanding Undergraduate Chemistry Student (2013)
- Distinguished Research Award in Biology (2013)
- Labs/Teams: Collaborates with labs focused on immunology, genetic engineering, and vaccine development at Yale School of Medicine.
۰مقاله منتشرشده